AI Analysis AI Analysis of PASG AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add PASG to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Big movements in Passage Bio, Inc. stock price on Friday moving 19.33% between high and low
(Updated on Jun 26, 2026)

Sell candidate since Jun 25, 2026 Gain 8.55%

The Passage Bio, Inc. stock price gained 8.55% on the last trading day (Friday, 26th Jun 2026), rising from $4.33 to $4.70. During the last trading day the stock fluctuated 19.33% from a day low at $4.19 to a day high of $5.00. The price has risen in 5 of the last 10 days but is still down by -16.07% for this period. Volume fell on the last day by -520 thousand shares and in total, 280 thousand shares were bought and sold for approximately $1.32 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -30.47% during the next 3 months and, with a 90% probability hold a price between $1.37 and $6.11 at the end of this 3-month period.

PASG Signals & Forecast

There are few to no technical positive signals at the moment. The Passage Bio, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $5.38 and $5.36. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Tuesday, June 23, 2026, and so far it has fallen -23.20%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not.

Support, Risk & Stop-loss for Passage Bio, Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $4.33 and $4.21. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Passage Bio, Inc. finds support just below today's level at $4.33. If this is broken, then the next support from accumulated volume will be at $4.21 and $4.12.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.81 between high and low, or 19.33%. For the last week the stock has had daily average volatility of 19.52%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (PASG) For The Upcoming Trading Day Of Monday 29th

For the upcoming trading day on Monday, 29th we expect Passage Bio, Inc. to open at $4.63, and during the day (based on 14 day Average True Range), to move between $4.38 and $5.02, which gives a possible trading interval of +/-$0.640 (+/-14.62%) up or down from last closing price. If Passage Bio, Inc. takes out the full calculated possible swing range there will be an estimated 14.62% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $5.03 (7.02%) than the support at $4.33 (7.87%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Passage Bio, Inc. stock A Buy?

Passage Bio, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -3.985 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 29, 2026 - $4.63 ( 1.49%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

PASG Performance

Trading levels for PASG

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 5.44 15.74%
R2 5.13 9.16%
R1 4.94 5.09%
Price 4.70
S1 4.32 -8.07%
S2 4.13 -12.14%
S3 3.82 -18.72%

Accumulated Volume Support & Resistance Levels

Level Price
R3 5.71 21.49%
R2 5.52 17.45%
R1 5.03 7.02%
Price 4.70
S1 4.33 -7.87%
S2 4.21 -10.43%
S3 4.12 -12.34%

FAQ

What is the symbol for Passage Bio, Inc. Stock and on which exchange is it traded?
The symbol for Passage Bio, Inc. is PASG and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Passage Bio, Inc. Stock?
Passage Bio, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Passage Bio, Inc. Stock?
Passage Bio, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Passage Bio, Inc. Stock.

What's the current price of Passage Bio, Inc. Stock?
As of the end of day on the Jun 26, 2026, the price of an Passage Bio, Inc. (PASG) share was $4.70.

What is the 52-week high and low for Passage Bio, Inc. Stock?
The 52-week high for Passage Bio, Inc. Stock is $20.00 and the 52-week low is $0.330.

What is the market capitalization of Passage Bio, Inc. Stock?
As of the Jun 26, 2026, the market capitalization of Passage Bio, Inc. is 15.077M.

When is the next earnings date for Passage Bio, Inc.?
The upcoming earnings date for Passage Bio, Inc. is Aug 11, 2026.
Click to get the best stock tips daily for free!
ABOUT PASSAGE BIO, INC.
Passage Bio
Passage Bio, Inc., a genetic medicines company, develops transformative therapies for central nervous system diseases. It develops PBGM01, which utilizes a proprietary, AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GLB1 gene encoding lysosomal acid beta-galactosidase for infantile GM1; PBFT02, which utilizes an AAV1 capsid to deliver to the brain a functional granulin (GRN) and gene encoding progranulin (PGRN) for the...
GOLDEN STAR
Ticker Change Signal Date
NMRK
$15.02
1.66% Jun 24
X
XMAX
$8.34
5.40% Jun 24
JLL
$299.78
5.10% Jun 24
NESR
$25.07
12.64% Jun 23
TTEK
$28.04
4.35% Jun 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE